Lower Relapse Rate of Botulinum Toxin A Therapy for Axillary Hyperhidrosis by Dose Increase

Botulinum toxin A for palmar hyperhidrosis

“…The acute side‐effects were not different from low‐dose treatment but long‐term efficacy was improved. The data are in accordance with our study on axillary hyperhidrosis using 200 U Botox per axilla 13,14 . In a recent study by Naver et al 17 .…”

Botulinum toxin A for palmar hyperhidrosis

“…The acute side‐effects were not different from low‐dose treatment but long‐term efficacy was improved. The data are in accordance with our study on axillary hyperhidrosis using 200 U Botox per axilla 13,14 . In a recent study by Naver et al 17 .…”

Axillary hyperhidrosis treated with botulinum toxin A exotoxin

“…With an injection of 3 MU BTX‐A into squares of 4 cm 2 at the axillary hyperhidrotic area, the effects of hyperhidrosis were observed within the follow‐up period for up to 5 months 5 . The treatment of axillary hyperhidrosis with high‐dose BTX‐A seems to be as safe as low‐dose BTX‐A and has a lower rate of relapse 9 . The results of the present study were similar to those in other studies.…”

Botulinum toxin treatment of secretory disorders

“…These studies supported the results of several previous open studies7–11, 14, 15 and one small controlled study on the treatment of axillary sweating with BoNT/A 11. Injection of higher doses (200 MU BOTOX per axilla)18 did not convincingly prolong the effect on hyperhidrosis compared with lower doses and is generally not recommended as it might cause systemic more side effects and increase the risk of antibody formation. Side effects included painful injections and small local hematomas.…”

Botulinum toxin A for palmar hyperhidrosis

“…The acute side‐effects were not different from low‐dose treatment but long‐term efficacy was improved. The data are in accordance with our study on axillary hyperhidrosis using 200 U Botox per axilla 13,14 . In a recent study by Naver et al 17 .…”

Axillary hyperhidrosis treated with botulinum toxin A exotoxin

“…With an injection of 3 MU BTX‐A into squares of 4 cm 2 at the axillary hyperhidrotic area, the effects of hyperhidrosis were observed within the follow‐up period for up to 5 months 5 . The treatment of axillary hyperhidrosis with high‐dose BTX‐A seems to be as safe as low‐dose BTX‐A and has a lower rate of relapse 9 . The results of the present study were similar to those in other studies.…”

Botulinum toxin treatment of secretory disorders

“…These studies supported the results of several previous open studies7–11, 14, 15 and one small controlled study on the treatment of axillary sweating with BoNT/A 11. Injection of higher doses (200 MU BOTOX per axilla)18 did not convincingly prolong the effect on hyperhidrosis compared with lower doses and is generally not recommended as it might cause systemic more side effects and increase the risk of antibody formation. Side effects included painful injections and small local hematomas.…”

Botulinum toxin A for palmar hyperhidrosis

“…The acute side‐effects were not different from low‐dose treatment but long‐term efficacy was improved. The data are in accordance with our study on axillary hyperhidrosis using 200 U Botox per axilla 13,14 . In a recent study by Naver et al 17 .…”

Axillary hyperhidrosis treated with botulinum toxin A exotoxin

“…With an injection of 3 MU BTX‐A into squares of 4 cm 2 at the axillary hyperhidrotic area, the effects of hyperhidrosis were observed within the follow‐up period for up to 5 months 5 . The treatment of axillary hyperhidrosis with high‐dose BTX‐A seems to be as safe as low‐dose BTX‐A and has a lower rate of relapse 9 . The results of the present study were similar to those in other studies.…”

Botulinum toxin treatment of secretory disorders

“…These studies supported the results of several previous open studies7–11, 14, 15 and one small controlled study on the treatment of axillary sweating with BoNT/A 11. Injection of higher doses (200 MU BOTOX per axilla)18 did not convincingly prolong the effect on hyperhidrosis compared with lower doses and is generally not recommended as it might cause systemic more side effects and increase the risk of antibody formation. Side effects included painful injections and small local hematomas.…”